Crestline Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,500
Closed -$424K 298
2022
Q1
$424K Buy
+16,500
New +$424K 0.05% 190